Stifel Nicolaus analyst Eric Le Berrigaud has maintained their neutral stance on RHHVF stock, giving a Hold rating today. Eric Le ...

In a report released today, Luisa Hector from Berenberg Bank maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with ...

Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household membersThis is the first time that any antiviral used in the treatment ...

Alectinib is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Central Nervous System (CNS) ...

Alectinib is under clinical development by F. Hoffmann-La Roche and currently in Phase II for High-Grade Glioma.

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Researchers at F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have described C-C chemokine receptor type 6 (CCR6) antagonists reported to be useful for the treatment of asthma, psoriasis, ...

Tecentriq Hybreza provides patients and physicians with greater flexibility of treatment options while showing safety and efficacy consistent with intravenous (IV) Tecentriq1,2New subcutaneous (SC) op ...

The leading Advanced Renal Cell Carcinoma Companies such as Merck Sharp & Dohme, Chia Tai Tianqing Pharmaceutical, Hoffmann-La Roche, CoImmune, Infinity Pharmaceuticals, NiKang Therapeutics ...

Report with market evolution powered by AI- The global hepatitis b and c diagnostics market size is estimated to grow by USD ...

David Clarke will become chair at ASX Ltd., the operator of Australia’s main equities and derivatives exchange that’s battled ...